Products
SentimenTrader Trading Tools
‍
Backtest Engine
My Trading Toolkit
Correlation Analysis
Seasonality
Market Prediction
Indicators & Data API
‍
Proprietary Indicators & Charts
Market Data API
Strategies & Scanner
‍
50+ Trading Strategies
Smart Stock Scanner
Smart Option Scanner
Research Reports
‍
Research Solutions
Reports Library
Free Resources
Simple Backtest Calculator
Simple Seasonality Calculator
The Kelly Criterion Calculator
Sentiment Geo Map
Public Research Reports
Education
Sentiment Indicators
Technical Indicators
Pricing
Company
About
In the News
Testimonials
Client Success Stories
Contact
Log inLoginSign up
< BACK TO ALL REPORTS

Daily Report : The surprising cyclicality of the biotech sector

Jason Goepfert
2023-06-19
The biotech sector has shown remarkably consistent cyclicality in the past 22 years. As detailed herein, investors and traders can gain an advantage by knowing where this sector stands regarding the annual seasonal trend.
View/Print a PDF version of this Report

Headlines


The surprising cyclicality of the biotech sector: The biotech sector has shown remarkably consistent cyclicality in the past 22 years. As detailed herein, investors and traders can gain an advantage by knowing where this sector stands regarding the annual seasonal trend.

Smart / Dumb Money Confidence

Smart Money Confidence: 18% Dumb Money Confidence: 80%

Risk Levels

Stocks Short-Term

Stocks Medium-Term

Bonds

Crude Oil

Gold

Agriculture

Research

The surprising cyclicality of the biotech sector

By Jay Kaeppel

BOTTOM LINE
The biotech sector has shown remarkably consistent cyclicality in the past 22 years. As detailed herein, investors and traders can gain an advantage by knowing where this sector stands regarding the annual seasonal trend.

FORECAST / TIMEFRAME
None

Key points

  • The biotech sector has shown consistent cyclicality in the past 22 years
  • Seasonality is usually best not used as a standalone trading model - still, it has been quite helpful to biotech traders who follow the cycles
  • Biotech just entered one of three notable seasonally favorable periods

The annual seasonal trend for IBB

The chart below displays the annual seasonal trend for the iShares Biotechnology ETF (ticker IBB).

Note that there are three distinct favorable periods within the calendar year.

  • TDY (Trading Day of Year) #113 through TDY #145
  • TDY #153 to TDY #179
  • TDY #197 to TDY #11 (of the next year)

How meaningful are these distinctions? Let's assess IBB's performance in the past 22+ years.

TDY #113 through #145

The chart below displays the growth of $1 if held in IBB only from the close of TDY #113 through TDY #145 each year since 2001. The cumulative gain equals +169%. For 2023, this period extends from the close on 2023-06-14 through the close on 2023-08-02.

TDY #153 through #179

The chart below displays the growth of $1 if held in IBB only from the close of TDY #153 through TDY #179 each year since 2001. The cumulative return equals +109%. For 2023, this period extends from the close on 2023-08-14 through the close on 2023-09-20.

TDY #197 through #11

The chart below displays the growth of $1 if held in IBB only from the close of TDY #197 through TDY #11 of the following year each year since 2001. The cumulative gain equals +326%. For 2023-24, this period extends from the close on 2023-10-16 through the close on 2024-01-17.

Combining favorable periods

As you can see in the charts above, none of these periods are ever a "sure thing." As shown in the table below, WIn Rates for these three periods range from 68% to 73%, so one never knows if a supposedly "favorable" period will show a gain in any given year. Still, in combination, there does appear that have some potential value.

The chart below assumes a trader held IBB only during the three favorable seasonal periods highlighted above every year since 2001. The cumulative hypothetical gain is +2,294% versus +286% for a buy-and-hold approach. 

Combining non-favorable periods

Let's focus solely on the non-favorable periods. The chart below assumes a trader held IBB during all trading days since 2001 that did not fall within one of the three favorable periods highlighted above. Strong rallies are not uncommon during these periods. Nevertheless, the long-term trend is unmistakable. The hypothetical cumulative return is -84%.

Summary of results

The chart below displays the growth of $1 held in IBB only during the three favorable periods highlighted above, divided by the growth of $1 held in IBB on a buy-and-hold basis.

The table below summarizes IBB's performance during all periods discussed above.

Some thoughts on real-world trading

The real question is, "What to do with this information?" The abovementioned seasonal approach has vastly outperformed buy-and-hold as a hypothetical standalone trading model. So, some might consider using a reasonable portion of investment capital to hold a long position during the three favorable seasonal periods. In this case, there are two things to keep in mind:

  • There is no guarantee whatsoever that future results will resemble past results
  • There is a question of drawdowns

In the interest of "keeping it real" and to highlight the potential dangers in relying on seasonality as a standalone trading method, note in the drawdown chart below that the "systematic" approach of holding IBB only during the three favorable seasonal periods each year witnessed a -32% maximum drawdown in the 2000-2002 bear market and three other separate drawdowns over -19% since. 

Whether you can - or even should - hold on through drawdowns of this magnitude is a question each trader must answer for themselves. One possibility (for this or any other volatile strategy) is to allocate a relatively small portion of one's total trading capital. A 30% drawdown on an allocation of 10% of total trading capital amounts to a decline of -3% of total trading capital, which might make it more palatable.

Another possibility for traders is to "favor the long side" of IBB during the favorable seasonal periods and "favor the short side" during all other periods. This application would involve a trader applying other indicators that they favor (chart patterns, technical indicators, etc.) to trigger an actual "buy" signal within one of the seasonally favorable periods (or an actual "sell short" signal within one of the non-favorable periods). The trader would also be responsible for capital allocation and position management decisions. 

What the research tells us…

There is a right way and a wrong way to use seasonality. As compelling as the results above may be, I rarely advocate holding (or not holding) something solely because of the date on the calendar. If such an approach is undertaken, it is prudent to do so with only a small capital allocation. Generally speaking, seasonality is best used to tell a trader or investor "where to look" and "which way to lean." With a favorable period in play, it might make sense to consider an allocation to the biotech sector between now and early August. However, assuming that IBB is sure to rally during this time would be a mistake.


Indicators at Extremes

Click here to view on the site (% Extremes and "Excess" tabs on the dashboard).
% Showing Pessimism: 7%
Bullish for Stocks

S&P 500 Down Pressure
Inverse ETF Volume
Rydex Bearish Flow
Mutual Fund Flow (no ETFs)
% Showing Optimism: 50%
Bearish for Stocks

Smart Money Confidence
% Showing Excess Optimism
VIX
VIX Term Structure
Smart Money / Dumb Money Confidence Spread
Equity Hedging Index
Short-term Optimism Index (Optix)
NYSE High/Low Ratio
Rydex Ratio
Rydex Money Market %
Dumb Money Confidence
Options Speculation Index
Equity Put/Call Ratio
Intermediate Term Optimism Index (Optix)
SKEW Index
Equity Put/Call Ratio De-Trended
OEX Put/Call Ratio
Stock/Bond Ratio
OEX Open Interest Ratio
AAII Bull Ratio
Risk Appetite Index
NAAIM Exposure Index
AIM (Advisor and Investor Model)
Retail Money Market Ratio
AAII Allocation - Stocks
NYSE Available Cash
Equity / Money Market Asset Ratio
Mutual Fund Cash Level
VIX Transform

Phase Table

Click here to view the Phase Table on the site.

Ranks

Click here to view on the site (Ranks tab on the Dashboard).

Sentiment Around The World

Click here to view on the site.

Optimism Index Thumbnails

Sector ETF's - 10-Day Moving Average
Country ETF's - 10-Day Moving Average
Bond ETF's - 10-Day Moving Average
Currency ETF's - 5-Day Moving Average
Commodity ETF's - 5-Day Moving Average
PRODUCTS
SentimenTrader
Trading Tools
Indicators & Data API
‍
Strategies & Scanner
‍
Research Reports
FREE
RESOUrCES
Simple Backtest
Calculator
Simple Seasonality
Calculator
The Kelly Criterion
Calculator
Sentiment Geo Map
‍
Public Research Reports
‍
Education
Sentiment Indicators
‍
Technical Indicators
‍
Pricing
Bundle pricing
‍
FAQ
‍
Announcements
‍
COMPANY
‍
About
‍
In the News
‍
Testimonials
‍
Client Success Stories
CONTACT
‍
General Inquiries
‍
Media Inquiries
‍
Financial Professionals Inquiries
‍
© 2026 Sundial Capital Research Inc. All rights reserved.
Setsail Marketing
TermsPrivacyAffiliate Program
Risk Disclosure: The information and tools provided are for research and analytical purposes only and are not intended as investment advice. Market analysis involves uncertainty, and outcomes may differ from expectations. Users should conduct their own due diligence and consider their individual circumstances before making any financial decisions. Past performance is not necessarily indicative of future results.

Hypothetical Performance Disclosure: Hypothetical performance results have many inherent limitations, some of which are described below. No representation is being made that any account will or is likely to achieve profits or losses similar to those shown; in fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. for example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted for in the preparation of hypothetical performance results and all which can adversely affect trading results.

Testimonial Disclosure: Testimonials appearing on this website may not be representative of other clients or customers and is not a guarantee of future performance or success.